TP53 and breast cancer: Also, p53 overexpression abrogated the regulating effects of gp96 overexpression on paclitaxel-resistance in PS-BC cells (Figures 2J, K), suggesting that intracellular gp96 controlled paclitaxel-resistance in BC cells in a p53-dependent manner.